Tim Atkin MW: Have we learnt from Covid-19?
Published: 27 July, 2020
After months of lockdown and the return to a palimpsest of normality – who would have guessed six months ago that weekend supplements would run features on how to choose the most flattering face masks for summer? – it’s understandable that the so-called Oxford vaccine has been greeted with such enthusiasm. AZD1222, developed by the university’s Jenner Institute and the drug giant AstraZeneca, certainly looks promising, even if it produces mild side effects in some users.
Read more...
